CareCloud, Inc. Q2 2026 Earnings Call Summary

Moby Intelligence

Fri, August 7, 2026 at 12:39 AM GMT+3 3 min read

CareCloud, Inc. Q2 2026 Earnings Call Summary - Moby

Strategic Execution and Operational Drivers

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

Achieved 16% revenue growth driven primarily by the integration of the Medsphere acquisition and a shift toward recurring technology-enabled solutions, which now represent 75% of total revenue.
Completed the full redemption of Series B preferred stock, eliminating approximately $3.3 million in annual dividends to simplify the balance sheet and increase earnings flow-through to common shareholders.
Entered the healthcare compliance and audit defense market via the acquisition of Empower Healthcare and Compliance Partners to address rising payer scrutiny and industry-wide denial rates.
Reported ninth consecutive quarter of GAAP profitability despite increased R&D spending to accelerate AI development and higher interest expense from the new credit facility used to retire preferred stock.
Executed a 'depth-before-breadth' implementation strategy for stratusAI Front Desk, prioritizing successful deployments over rapid volume to ensure durable recurring revenue.
Modernized legacy platforms by completing parity gaps for Inpatient Revenue Cycle and CareVue, while integrating AI notes and patient experience layers into the Wellsoft emergency department workflow.

Second Half 2026 Outlook and Strategic Roadmap

Reaffirmed full-year 2026 guidance, implying a significantly stronger second half driven by seasonality, enterprise client expansion, and the full-period impact of eliminated preferred dividends.
Planned launch of AI-enabled compliance software in fall 2026 to convert Empower's professional expertise into a scalable, recurring SaaS revenue model.
Anticipated margin improvement in the second half as integration costs and 'tech debt' remediation for recent acquisitions move into the rearview mirror.
Advancing a multi-year vision to consolidate independent back-ends into a single modular platform with a unified patient record and common AI foundation.
Guidance assumes timely execution of expense management initiatives and the successful conversion of the current sales pipeline into recognized revenue.

Risk Factors and Structural Adjustments

Established a $60 million at-the-market (ATM) equity program to provide flexible capital for future growth opportunities when market conditions are favorable.
Managed a March 2026 cyber incident affecting a single environment; management believes insurance will cover related costs and that there is no material impact on operations.
Transitioned to a $50 million credit facility with Citizens Bank and Provident Bank to fund the Series B redemption, replacing high-cost preferred equity with lower-cost debt.
Increased R&D expense reflects a strategic shift toward expensing rather than capitalizing AI development costs to build long-term durable earnings power.

Q&A Session Highlights

Drivers for projected second half 2026 financial outperformance

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.

Management expects a ramp to $33 million-$34 million in quarterly revenue driven by natural seasonality and the layering of growth from Empower cross-selling.
Profitability is expected to rise as the 'lion's share' of Medsphere integration efforts and accelerated amortization of intangibles decrease over time.

Strategic rationale and financial impact of Empower acquisition

The acquisition followed a disciplined playbook with a low upfront payment (30% of trailing revenue) and an earn-out structure aligned with growth targets.
Beyond immediate revenue, the deal provides a foothold in audit defense through the acquisition of Empower, whose founder has already referred business representing 10% of CareCloud's current annualized revenue.

Status of AI-powered platform engagement with private equity

Management confirmed active conversations with a large, private equity-backed enterprise client regarding an AI-powered platform engagement.
The potential deal serves as a validation of CareCloud's AI capabilities, though management declined to share specific scope or timelines until the deal materializes.

Sales force expansion and cross-selling effectiveness

The sales force has been significantly expanded, primarily through personnel joined via the Medsphere acquisition who are already familiar with the applications.
The strategy remains focused on cross-selling to existing customers, which management noted is more cost-effective than pursuing net-new wins.